Improved insurance coverage likely drove increased adoption of Semglee (insulin glargine-yfgn) rather than its status as an interchangeable biosimilar of Lantus, according to new research published in ...

Medicare Open Enrollment for Part D drug plans ends on December 7th. Don't miss this chance to change plans for 2026.

When Crystal Gonzalez was diagnosed with diabetes in 2023, she felt lost. Balancing parenthood with her job was already a challenge, she said. The diagnosis added a new layer of complexity to her life ...